Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Guide5 min read

How Long Does It Take for Semaglutide to Work?

Wondering when you'll see results on semaglutide? Here's a realistic week-by-week timeline of what to expect - from appetite changes to visible weight loss.

Updated September 15, 2026

Medically reviewed on

How we review

Week 1-2: Appetite Changes Begin

Most patients notice the first effects within the first two weeks of starting semaglutide. The most common early sign is reduced appetite - food simply doesn't occupy as much mental space.

You may feel full faster at meals or notice that cravings for specific foods (especially sugar and processed snacks) begin to quiet. At this stage, you're on the lowest starting dose, so effects are typically subtle.

Read our first month guide for more detail.

Our top 2 picks

Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review

Week 3-4: Early Weight Loss

By the end of the first month, many patients see 3-5 pounds of weight loss, though this varies widely. The scale is only part of the picture - changes in how clothes fit, energy levels, and your relationship with food are equally important early indicators.

Some patients lose more, some less. Remember: you're still on a low dose.

Month 2-3: Dose Increases and Acceleration

As your provider gradually increases your dose (the standard titration schedule), appetite suppression becomes more pronounced and weight loss typically accelerates. Most patients see the most significant month-over-month changes during this period. By month 3, many patients have lost 5-10% of their starting weight. Nutrition and exercise habits amplify results during this phase.

Month 4-6: Steady Progress

Weight loss continues at a steady pace as you approach your maintenance dose. The rate may slow compared to months 2-3, which is normal - your body is adjusting.

Patients who combine medication with high protein intake and regular strength training tend to maintain the best momentum. If progress stalls, see our guide on breaking through plateaus.

Shop semaglutide plans by provider

Published semaglutide plans - cheapest first, conditions under each price.

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

Month 6-12+: Maximum Results

Clinical trials show the most significant results at 68 weeks (about 16 months), with average weight loss of 15% of body weight. Most patients reach their peak results between months 9-15.

After reaching your goal, discuss a maintenance plan with your provider - some patients step down to a lower dose rather than stopping entirely. Read about what happens when you stop.

Does Exercise Speed Up Results?

Yes - patients who combine semaglutide with regular exercise, especially strength training, tend to see faster and more sustainable results. Exercise also helps preserve lean muscle during weight loss, which is critical for long-term metabolism. See our exercise guide for GLP-1 patients.

How to Track Your Progress

Don't rely solely on the scale. Track waist measurements, how clothes fit, energy levels, and appetite changes.

Some patients lose inches before they see scale movement. Taking progress photos monthly can also reveal changes that day-to-day weighing misses. Find a provider that includes progress tracking in their program.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)